Screener
Asset Entities ASST Medical Device — Marketing and advertising
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:MarketingAndAdvertisingExpense.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Fund management and administration | 1,489 | 1,588 |
| Employee compensation and benefits | 16,314 | 2,005 |
| General and administrative expense | 6,428 | 1,452 |
| Marketing and advertising | 79 | 102 |
| Depreciation and amortization | 86 | 54 |
| Total operating expenses | 24,396 | 5,201 |
| Investment losses: | ||
| Net unrealized loss on digital assets, at fair value | (228,031) | — |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — marketing and advertising?
- Asset Entities (ASST) reported medical device — marketing and advertising of $3K in Q2 2026.
- What does medical device — marketing and advertising mean?
- This metric tracks the expenditures dedicated to promoting the segment's products or services to potential customers. It measures the company's investment in brand awareness, lead generation, and market penetration for this specific business unit. Analyzing this spend relative to revenue growth helps determine the effectiveness of the segment's marketing strategy.
Ask your AI about Asset Entities's medical device — marketing and advertising.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude